Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
03/05/2009 | US20090062356 Substituted benzimidazole derivatives |
03/05/2009 | US20090062351 Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators |
03/05/2009 | US20090062320 Method of Treating Disorders Mediated by the Fibroblast Growth Factor Receptor |
03/05/2009 | US20090062276 Pyridopyrimidine protein tyrosine phosphatase inhibitors |
03/05/2009 | US20090062269 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
03/05/2009 | US20090062260 Compounds and compositions as lxr modulators |
03/05/2009 | US20090062231 Appetite Suppressant Composition and Method of Appetite Suppression |
03/05/2009 | US20090062215 Application of d-psicose to suppression of abnormal circadian increase in blood glucose level |
03/05/2009 | US20090062201 Integrin binding motif containing peptides and methods of treating skeletal diseases |
03/05/2009 | US20090062193 Compositions and methods for the control, prevention and treatment of obesity and eating disorders |
03/05/2009 | US20090062192 Dimeric Peptide Agonists of the Glp-1 Receptor |
03/05/2009 | US20090062187 Use of Hmgb1 for Wound Healing |
03/05/2009 | US20090062180 Polypeptide biodrugs with given amino acid sequence which includes phosphorylated serine or threonine conjugated to a hydrophobic moiety such as a fatty acid; treating disorders such as Type II Diabetes, neurodegenerative diseases and psychological disorders |
03/05/2009 | US20090061031 Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus |
03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
03/05/2009 | US20090060943 Syndrome X Composition and Method of Lowering Blood Pressure and Glycemic Index |
03/05/2009 | US20090060941 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
03/05/2009 | US20090060925 Rage Fusion Proteins and Methods of Use |
03/05/2009 | US20090060920 Desacyl ghrelin antibodies and therapeutic uses thereof |
03/05/2009 | US20090060905 Use of 15-Lipoxygenase Inhibitors for Treating Obesity |
03/05/2009 | US20090060900 Methods for Screening Compounds That Modulate Lipid Metabolism |
03/05/2009 | US20090060894 Treatment to aid in the metabolism of alcohol |
03/05/2009 | US20090060887 Method for treating the pancreas of a human patient |
03/05/2009 | US20090060883 Composition for promotion of bone growth and maintenance of bone health |
03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
03/05/2009 | US20090060861 Stabilized Polypeptide Formulations |
03/05/2009 | CA2697990A1 Medication combinations for the treatment of alcoholism and drug addiction |
03/05/2009 | CA2697167A1 Benzimidazole derivatives used as fxr agonists |
03/05/2009 | CA2696898A1 Process for the preparation of pyrido [2,1-a] isoquinoline derivatives and polymorphic forms thereof |
03/04/2009 | EP2031057A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
03/04/2009 | EP2030986A1 Polypeptide derivative of parathyroid hormone (PTH) |
03/04/2009 | EP2030629A1 Lipid-metabolism-improving agent |
03/04/2009 | EP2030623A1 Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
03/04/2009 | EP2029610A2 Novel mch receptor antagonists |
03/04/2009 | EP2029609A2 Novel mch receptor antagonists |
03/04/2009 | EP2029601A1 Pyridopyrimidinone derivatives |
03/04/2009 | EP2029596A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
03/04/2009 | EP2029579A2 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
03/04/2009 | EP2029576A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
03/04/2009 | EP2029558A2 Compounds and methods for modulating fxr |
03/04/2009 | EP2029547A1 Fxr agonists |
03/04/2009 | EP2029534A2 1h-indol-5-yl-piperazin-1-yl-methanone derivatives |
03/04/2009 | EP2029529A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
03/04/2009 | EP2029231A1 Use of alpha-lactalbumin for regulation of glycemia |
03/04/2009 | EP2029160A2 Methods to restore glycemic control |
03/04/2009 | EP2029145A2 Pyrrolopyrimidine compounds and their uses |
03/04/2009 | EP2029138A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
03/04/2009 | EP2029101A2 Type-2 diabetes combination wafer |
03/04/2009 | EP1836187B1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
03/04/2009 | EP1695983B1 Glucagon-like peptide-1 analogs |
03/04/2009 | EP1515984B1 Peptide derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
03/04/2009 | EP1506951B1 Method for the preparation of total salvianolic acid |
03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
03/04/2009 | EP1408931B1 Isotonic lipid emulsions |
03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
03/04/2009 | EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists |
03/04/2009 | EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity |
03/04/2009 | EP0869974B1 Compounds with growth hormone releasing properties |
03/04/2009 | CN101379086A Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
03/04/2009 | CN101379036A Anthranilamide/2-amino-heteroarene carboxamide derivatives |
03/04/2009 | CN101378807A Combination of an H3 antagonist/inverse agonist and an appetite suppressant |
03/04/2009 | CN101378667A High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
03/04/2009 | CN101378666A Carbohydrate composition for flat glucose response |
03/04/2009 | CN101376016A Method for preparing Chinese medicine for treating hyperlipemia |
03/04/2009 | CN101375978A Medicinal composition for lowering blood fat |
03/04/2009 | CN101375972A Health oral liquid and its preparation |
03/04/2009 | CN101375962A Formulation for activating blood and freeing collateral vessels and preparation method thereof |
03/04/2009 | CN101375961A Application of plant or herbal medicine as well as volatile oil extract thereof in preparing medicament for treating diabetes |
03/04/2009 | CN101375959A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
03/04/2009 | CN101375958A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375957A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375956A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375945A Gingko leaf, guava leaf, honeybee series vitamin preparation and preparation technique thereof |
03/04/2009 | CN101375944A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375943A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375942A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375941A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375933A Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds |
03/04/2009 | CN101375930A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
03/04/2009 | CN101375929A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375928A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375927A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375926A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375923A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375922A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375921A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375920A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375919A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375918A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375916A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
03/04/2009 | CN101375914A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375913A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375912A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375911A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375910A Pharmaceutical combination for preventing birth-defect and improving memory |
03/04/2009 | CN101375908A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
03/04/2009 | CN101375907A Pharmaceutical combination for preventing birth-defect and improving memory |